Shenzhen GTJA Investment Group
Shenzhen, Guangdongszgig.com
Overview
Shenzhen GTJA Investment Group is a private equity and venture capital firm that focuses on growth stage investments and buyout deals, primarily in the healthcare industry in China . The firm was established in March 2001 and has operation centers in Shenzhen, Shanghai, Beijing, Nanjing, and Hong Kong . They are committed to investing in medical and health enterprises .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Degron Therapeutics | May 2026 | Series A Extension | Co-investor |
| The Pharma Letter | May 2026 | Series A Extension | Co-investor |
| Infinity Neuro | Dec 2025 | Series A | Lead |
| BridGene Biosciences | Oct 2025 | Series B Extension | Co-investor |
| Tennor Therapeutics | Feb 2022 | Series D | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
